Tenet Healthcare (THC) Cash & Equivalents (2009 - 2026)

Tenet Healthcare's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $3.0 billion for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 1.07% year-over-year to $3.0 billion; the TTM figure through Mar 2026 stood at $3.0 billion (down 1.07% YoY), while the FY2025 annual figure was $2.9 billion, down 4.5% from the prior year.
• Cash & Equivalents came in at $3.0 billion for Q1 2026 at Tenet Healthcare, up from $2.9 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $4.1 billion in Q3 2024 to a low of $766.0 million in Q1 2023.
• A 5-year average of $2.1 billion and a median of $2.5 billion in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 63.71% in 2022 and soared 288.43% in 2024, its largest moves.
• Tenet Healthcare's Cash & Equivalents stood at $858.0 million in 2022, then surged by 43.12% to $1.2 billion in 2023, then soared by 145.85% to $3.0 billion in 2024, then slipped by 4.5% to $2.9 billion in 2025, then grew by 2.91% to $3.0 billion in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $3.0 billion, $2.9 billion, and $3.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison